The expression of AKR1B10 positively correlated with lymph node metastasis, tumor size, Ki67 expression, and p53 expression, but inversely correlated with overall and disease-free survival rates. This evidence concerns the gene AKR1B10 and metastatic malignant neoplasm in the lymph nodes.